HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabio Ciceri Selected Research

Proteins (Proteins, Gene)

10/2021CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
8/2013Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
10/2007Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabio Ciceri Research Topics

Disease

112Leukemia
05/2024 - 11/2002
98Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 01/2006
75Graft vs Host Disease (Graft-Versus-Host Disease)
05/2024 - 01/2002
63COVID-19
04/2024 - 01/2020
57Neoplasms (Cancer)
03/2024 - 01/2002
33Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2024 - 04/2009
27Infections
10/2023 - 11/2004
26Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 01/2002
14Multiple Myeloma
12/2023 - 12/2002
13Lymphoma (Lymphomas)
12/2023 - 09/2004
12Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2024 - 07/2009
12Pneumonia (Pneumonitis)
02/2022 - 01/2020
9Inflammation (Inflammations)
04/2024 - 07/2014
8Pathologic Complete Response
05/2024 - 01/2002
8Philadelphia Chromosome
01/2021 - 08/2010
7Fever (Fevers)
01/2024 - 07/2014
7Hodgkin Disease (Hodgkin's Disease)
12/2023 - 03/2008
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2020 - 07/2008
6Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
02/2024 - 01/2009
6Severe combined immunodeficiency due to adenosine deaminase deficiency
02/2024 - 01/2009
6Residual Neoplasm
01/2022 - 04/2009
5Autoimmune Diseases (Autoimmune Disease)
03/2024 - 05/2011
5Primary Myelofibrosis (Myelosclerosis)
02/2024 - 09/2016
5Hematologic Diseases (Blood Diseases)
12/2023 - 03/2010
5Respiratory Insufficiency (Respiratory Failure)
11/2023 - 01/2021
5Disease Progression
01/2023 - 06/2005
5beta-Thalassemia (Cooley's Anemia)
06/2011 - 09/2007
4Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2023 - 11/2009
4Multiple Sclerosis
01/2023 - 06/2005
4Cytokine Release Syndrome
11/2021 - 01/2018
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 09/2004
4Metachromatic Leukodystrophy (Sulfatide Lipidosis)
12/2019 - 08/2013
4Thalassemia
01/2019 - 05/2010
3Communicable Diseases (Infectious Diseases)
01/2024 - 12/2021
3Neutropenia
01/2023 - 01/2009

Drug/Important Bio-Agent (IBA)

64Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2024 - 01/2002
24AntigensIBA
04/2024 - 11/2004
17Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2006
15Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
05/2024 - 01/2017
13treosulfanIBA
02/2024 - 08/2015
13Busulfan (Busulfex)FDA Link
02/2024 - 01/2009
12HLA Antigens (Human Leukocyte Antigens)IBA
11/2022 - 11/2008
11Methotrexate (Mexate)FDA LinkGeneric
04/2024 - 12/2009
10fludarabineIBA
02/2024 - 01/2002
10CytokinesIBA
01/2022 - 11/2004
9Interleukin-6 (Interleukin 6)IBA
11/2023 - 01/2018
9C-Reactive ProteinIBA
09/2023 - 11/2005
9Rituximab (Mabthera)FDA Link
11/2020 - 07/2008
8Tyrosine Kinase InhibitorsIBA
01/2022 - 10/2016
8Thymidine KinaseIBA
06/2013 - 11/2002
7Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2024 - 12/2009
7VaccinesIBA
12/2023 - 02/2009
7SteroidsIBA
01/2023 - 11/2004
6Sirolimus (Rapamycin)FDA Link
07/2023 - 01/2011
6Chimeric Antigen ReceptorsIBA
01/2023 - 01/2018
6Interleukin-1 (Interleukin 1)IBA
04/2021 - 01/2018
5Complement System Proteins (Complement)IBA
04/2024 - 01/2020
5Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2024 - 03/2016
5Calcineurin InhibitorsIBA
04/2024 - 03/2016
5Adenosine DeaminaseIBA
02/2024 - 01/2009
5Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
12/2023 - 01/2002
5T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2023 - 05/2012
5Testosterone (Sustanon)FDA Link
11/2023 - 01/2021
5Hemoglobins (Hemoglobin)IBA
08/2023 - 11/2005
5Monoclonal AntibodiesIBA
01/2021 - 01/2018
4Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
11/2023 - 01/2018
4Immunoglobulin G (IgG)IBA
01/2023 - 10/2020
4EnzymesIBA
01/2023 - 09/2008
4Oxygen (Dioxygen)IBA
01/2023 - 09/2020
4AutoantibodiesIBA
01/2022 - 10/2020
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2019
4Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 10/2007
4TroponinIBA
01/2022 - 01/2018
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2022 - 08/2015
4AntibodiesIBA
11/2021 - 05/2010
3Melphalan (Alkeran)FDA LinkGeneric
12/2023 - 08/2015
3Cytarabine (Cytosar-U)FDA LinkGeneric
11/2023 - 11/2015
3Etoposide (VP 16)FDA LinkGeneric
11/2023 - 11/2015
3letermovirIBA
10/2023 - 01/2019
3GlobinsIBA
08/2023 - 04/2011
3InterleukinsIBA
01/2023 - 10/2020
3Carbapenems (Carbapenem Antibiotics)IBA
01/2023 - 09/2015
3fibrin fragment D (D-dimer)IBA
01/2023 - 09/2020
3Ferritins (Ferritin)IBA
01/2023 - 06/2012
3Interleukin-10 (Interleukin 10)IBA
01/2023 - 01/2014

Therapy/Procedure

103Transplantation
05/2024 - 01/2002
96Hematopoietic Stem Cell Transplantation
05/2024 - 01/2006
75Stem Cell Transplantation
05/2024 - 11/2002
53Cell Transplantation
04/2024 - 11/2002
53Therapeutics
03/2024 - 06/2005
32Drug Therapy (Chemotherapy)
03/2024 - 03/2008
22Haploidentical Transplantation
05/2024 - 07/2009
16Homologous Transplantation
04/2024 - 01/2002
16Immunotherapy
12/2023 - 11/2004
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2021 - 09/2014
5Autologous Transplantation
08/2020 - 05/2010
4Aftercare (After-Treatment)
05/2024 - 01/2023
4Noninvasive Ventilation
11/2023 - 06/2020
4Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2022 - 01/2017
4Radiotherapy
04/2014 - 06/2009